Logo-apb
Adv Pharm Bull. 2021;11(2): 343-350. doi: 10.34172/apb.2021.032
PMID: 33880357        PMCID: PMC8046387

Research Article

Multiplex Genome Editing in Chinese Hamster Ovary Cell Line Using All-in-One and HITI CRISPR Technology

Fatemeh Safari 1,2 ORCID, Safar Farajnia 3 * ORCID, Younes Ghasemi 4, Nosratollah Zarghami 1, Mazyar Barekati Mowahed 5

Cited by CrossRef: 4

1- Kalkan A, Palaz F, Sofija S, Elmousa N, Ledezma Y, Cachat E, Rios-Solis L. Improving recombinant protein production in CHO cells using the CRISPR-Cas system. Biotechnology Advances. 2023;64:108115 [Crossref]
2- Rahimi A, Karimipoor M, Mahdian R, Alipour A, Hosseini S, Kaghazian H, Abbasi A, Shahsavarani H, Shokrgozar M. Targeting Caspase-3 Gene in rCHO Cell Line by CRISPR/Cas9 Editing Tool and Its Effect on Protein Production in Manipulated Cell Line. Iran J Pharm Res. 2023;21(1) [Crossref]
3- Safari F, Afarid M, Rastegari B, Borhani-Haghighi A, Barekati-Mowahed M, Behzad-Behbahani A. CRISPR systems: Novel approaches for detection and combating COVID-19. Virus Research. 2021;294:198282 [Crossref]
4- Sarma S, Thomas S, Kamat R. It takes two to tango with CRISPR: a history and overview of augmenting the technology for genetic engineering. ProcIndian Natl Sci Acad. 2024;90(4):840 [Crossref]

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by